Potential Bile Acid Precursors in Plasma--possible Indicators of Biosynthetic Pathways to Cholic and Chenodeoxycholic Acids in Man
Overview
Affiliations
The plasma concentrations of 3 beta-hydroxy-5-cholestenoic acid, 3 beta,7 alpha-dihydroxy-5-cholestenoic acid and 7 alpha-hydroxy-3-oxo-4-cholestenoic acid have been compared with that of 7 alpha-hydroxy-4-cholesten-3-one in healthy subjects and in patients with an expected decrease or increase of the bile acid production. In controls and patients with liver disease, the level of 7 alpha-hydroxy-3-oxo-4-cholestenoic acid was positively correlated to that of 3 beta,7 alpha-dihydroxy-5-cholestenoic acid and not to that of 7 alpha-hydroxy-4-cholesten-3-one. In patients with stimulated bile acid formation the levels of the acids were not correlated to each other but there was a significant positive correlation between the levels of 7 alpha-hydroxy-3-oxo-4-cholestenoic acid and 7 alpha-hydroxy-4-cholesten-3-one. These findings indicate that the precursor of 7 alpha-hydroxy-3-oxo-4-cholestenoic acid differs depending on the activity of cholesterol 7 alpha-hydroxylase. Since the activity of this enzyme is reflected by the level of 7 alpha-hydroxy-4-cholesten-3-one in plasma the findings are compatible with a formation of 7 alpha-hydroxy-3-oxo-4-cholestenoic acid from 3 beta,7 alpha-dihydroxy-5-cholestenoic acid when the rate of bile acid formation is normal or reduced and from 7 alpha-hydroxy-4-cholesten-3-one under conditions of increased bile acid synthesis. In support of this interpretation, 7 alpha,26-dihydroxy-4-cholesten-3-one was identified at elevated levels in plasma from patients with ileal resection or treated with cholestyramine. The levels of 7 alpha,12 alpha-dihydroxy-4-cholesten-3-one were also higher than normal in these patients. Based on these findings and previous knowledge, a model is proposed for the biosynthesis of bile acids in man. Under normal conditions, two major pathways, one "neutral" and one "acidic" or "26-oxygenated", lead to the formation of cholic acid and chenodeoxycholic acid, respectively. These pathways are separately regulated. When the activity of cholesterol 7 alpha-hydroxylase is high, the "neutral" pathway is most important whereas the reverse is true when cholesterol 7 alpha-hydroxylase activity is low. In cases with enhanced activity of cholesterol 7 alpha-hydroxylase, the "neutral" pathway is connected to the "acidic" pathway via 7 alpha,26-dihydroxy-4-cholesten-3-one, whereas a flow from the acidic pathway to cholic acid appears to be of minor importance.
Hu W, Zhu J, Zhang Q, Lu X, Yu L, Li B MedComm (2020). 2025; 6(3):e70110.
PMID: 40046408 PMC: 11879897. DOI: 10.1002/mco2.70110.
Carcinogenic and anticancer activities of microbiota-derived secondary bile acids.
Kouhzad M, Gotz F, Navidifar T, Taki E, Ghamari M, Mohammadzadeh R Front Oncol. 2025; 15:1514872.
PMID: 39944822 PMC: 11813773. DOI: 10.3389/fonc.2025.1514872.
Bile acid metabolism in type 2 diabetes mellitus.
Cadena Sandoval M, Haeusler R Nat Rev Endocrinol. 2025; .
PMID: 39757322 DOI: 10.1038/s41574-024-01067-8.
Mitochondria at the Crossroads of Cholestatic Liver Injury: Targeting Novel Therapeutic Avenues.
Li X, Ruan T, Wang S, Sun X, Liu C, Peng Y J Clin Transl Hepatol. 2024; 12(9):792-801.
PMID: 39280065 PMC: 11393838. DOI: 10.14218/JCTH.2024.00087.
The Intestinal Microbiota in the Development of Chronic Liver Disease: Current Status.
Stojic J, Kukla M, Grgurevic I Diagnostics (Basel). 2023; 13(18).
PMID: 37761327 PMC: 10528663. DOI: 10.3390/diagnostics13182960.